Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
4 participants
INTERVENTIONAL
2012-08-31
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Gum Chewing on Ileus in Chinese Colorectal Patients Underwent Laparoscopic Colorectal Surgery
NCT02419586
The Effect of Gum Chewing on Bowel Motility in Post-operative Colon Resection Patients
NCT01613274
Effect of Gum Chewing on Bowel Cleansing Before Colonoscopy
NCT02507037
Does Chewing Gum After Elective Laparoscopic Colectomy Surgery Decrease Ileus?
NCT00632801
Impact of Chewing Gum on Bowel Preparation in Patients Undergoing Colonoscopy
NCT07320989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nicotine gum
100 subjects who will actually get the intervention medication
Nicotine gum
Patients will chew nicotine gum 3 times a day until discharge or 7 days, whichever comes first
regular chewing gum
100 subjects who will be part of a control group
Regular chewing gum
Patients will chew regular sugar-free gum 3 times a day until discharge or 7 days, whichever comes first
No gum
100 subjects who will not get neither the intervention nor the placebo gum.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nicotine gum
Patients will chew nicotine gum 3 times a day until discharge or 7 days, whichever comes first
Regular chewing gum
Patients will chew regular sugar-free gum 3 times a day until discharge or 7 days, whichever comes first
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Due to undergo small and/or large partial bowel resection via laparotomy or laparoscopy;
Exclusion Criteria
* Mentally incompetent or unable or unwilling to provide informed consent or comply with study procedures
* American Society of Anesthesiologists (ASA) Class IV or V;
* History of abdominal carcinomatosis;
* History of radiation enteritis;
* Children \< 18 or adults \> 85 years of age
* Pregnant women
* Current cigarette, cigar smokers and chewers of tobacco. ex smokers who quit less than 3 months ago.
* Patients requiring postoperative ventilation, pressor requirement or ICU stay
* Patients with prior cardiovascular disorders
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Cleveland Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eric Weiss
DIO and Chairman of Graduate Medical Education at Cleveland Clinic Florida,
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ERIC G WEISS, MD
Role: PRINCIPAL_INVESTIGATOR
Cleveland Clinic Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cleveland Clinic Florida
Weston, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRS-2012-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.